IP Verse

Biogen Ma Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Biogen Ma Inc. opposed by its competitors

Patent:
EP2645106
Grant Date:
Oct 2, 2024
Title:
Methods And Products For Evaluating An Immune Response To A Therapeutic Agent
Oppositions:
1
Patent:
EP3036320
Grant Date:
Apr 3, 2024
Title:
Control Of Protein Glycosylation By Culture Medium Supplementation And Cell Culture Process Parameters
Oppositions:
1
Patent:
EP2956477
Grant Date:
Jan 24, 2024
Title:
Optimized Factor Viii Gene
Oppositions:
1
Patent:
EP2701778
Grant Date:
Oct 18, 2023
Title:
A Limiter For A Dispensing Device
Oppositions:
2
Patent:
EP2972238
Grant Date:
Apr 26, 2023
Title:
Use Of Raman Spectroscopy To Monitor Culture Medium
Oppositions:
2
Patent:
EP3339865
Grant Date:
Dec 14, 2022
Title:
Assay For Jc Virus Antibodies
Oppositions:
1
Patent:
EP3575792
Grant Date:
Nov 30, 2022
Title:
Method Of Assessing Risk Of Pml
Oppositions:
2
Patent:
EP2653873
Grant Date:
Aug 24, 2022
Title:
Compositions And Uses For Treating Multiple Sclerosis
Oppositions:
14
Patent:
EP3122869
Grant Date:
Aug 10, 2022
Title:
Methods For Overcoming Glutamine Deprivation During Mammalian Cell Culture
Oppositions:
1
Patent:
EP2870250
Grant Date:
Jun 29, 2022
Title:
Cell Line Expressing Single Chain Factor Viii Polypeptides And Uses Thereof
Oppositions:
2

Competitors of Biogen Ma Inc.

POLPHARMA BIOLOGICS S.A.

PHARMACEUTICAL WORKS POLPHARMA SA

GRUNECKER PATENT- UND RECHTSANWALTE PARTG MBB

Want to track Biogen Ma Inc.?

Feel free to send us a message here and we will get back to you